has received consulting fees on behalf of Newcastle University from 89bio, Akero, Alimentiv, AstraZeneca, Axcella, Boehringer Ingelheim, Bristol Myers Squibb, Galmed, Genentech, Genfit, Gilead, GlaxoSmithKline, Hanmi, HistoIndex, Intercept, Inventiva, Ionis, IQVIA, Janssen, Madrigal, Medpace, Merck, NGMBio, Novartis, Novo Nordisk, PathAI, Pfizer, Pharmanest, Poxel, Prosciento, Resolution Therapeutics, Ridgeline Therapeutics, Roche, RTI, Shionogi and Terns Pharmaceuticals
Effect of alpha-lipoic acid on oxidative stress parameters: A systematic review and meta-analysis
Barry Conrad Yep
It's not a spot-reduction treatment, and it shouldn't be confused with fat-dissolving injections, which are an entirely different product category with a different risk profile (more on that below)
Do I need to take them all